Abstract：OBJECTIVE To guide pharmaceutical manufacturing to pay full attention to andimplement the quality control and overall requirements of preparation production based on theanalysis of the revision work and major changes of the Dosage Forms General Chapters of the 2020 edition of the Chinese Pharmacopoeia. METHODSE This article mainly introduces the compilation progress of the Dosage Forms General Chapters of the 2020 edition of the Chinese Pharmacopoeia. RESULTS The analysis is helpful to improve the integrity, advancement and readability of the Dosage Forms General Chapters of the 2020 edition of the Chinese Pharmacopoeia. CONCLUSION The improvement of the Dosage Forms General Chapters of the 2020 edition of the Chinese Pharmacopoeia will play an important role in improving the overall level of Chinese pharmacopoeia standards, strengthening drug quality control and improving drug quality.
尚悦, 宋宗华, 周建平, 杨昭鹏. 2020年版《中国药典》四部制剂通则增修订及主要特点概述与浅析[J]. 中国药学杂志, 2020, 55(14): 1167-1171.
SHANG Yue, SONG Zong-hua, ZHOU Jian-ping, YANG Zhao-peng. Development and Revision of Dosage Forms General Chapters of Chinese Pharmacopeia 2020 Edition Volume Ⅳ. Chinese Pharmaceutical Journal, 2020, 55(14): 1167-1171.
ZHANG W, LAN F, HONG X X. Overview on the Chinese Pharmacopoeia 2015 Edition[J]. Chin Pharm J(中国药学杂志),2015,50(20):1743-1746.
[2]
Ch.P. Notice on the compilation Outline of The 2020 Edition of The Chinese Pharmacopoeia[EB/OL]. [2018-01-30] http://www.chp.org.cn/view/ff8080815e0d584f01614671d79d5753?a=tz.
2020, Vol. 55 
